Gene expression profiling of human kidneys undergoing laparoscopic donor nephrectomy

Area of Science:

• Nephrology
• Genomics
• Surgical Innovation

Background:

• Donor nephrectomy is crucial for kidney transplantation.
• Laparoscopic donor nephrectomy with carbon dioxide pneumoperitoneum is a common surgical approach.
• Potential renal injury from laparoscopic procedures requires investigation.

Purpose of the Study:

• To compare gene expression profiles of kidneys from open versus laparoscopic donor nephrectomy.
• To identify differentially expressed genes and associated molecular pathways.
• To screen for small-molecule drugs that could mitigate surgical effects.

Main Methods:

• Utilized DNA microarrays to analyze gene expression profiles (GSE3297) from donor kidneys.
• Employed bioinformatics approaches, including Osprey, DAVID, and FuncAssociate, for data analysis.
• Screened for small-molecule drugs using the Connectivity Map.

Main Results:

• Identified 285 differentially expressed genes (148 down-regulated, 137 up-regulated).
• Key genes identified include CASP6, KRAS, SOCS1, and STAT1, involved in inflammation and immune pathways.
• Luteolin was identified as a potential therapeutic small molecule with the highest score (0.887).

Conclusions:

• Laparoscopic donor nephrectomy with carbon dioxide pneumoperitoneum induces significant alterations in the renal transcriptome.
• These alterations are characterized by increased expression of genes related to acute inflammation, apoptosis, and immune injury.
• Findings suggest potential for renal injury and enhanced immune response in transplant recipients, highlighting the need for targeted therapies.